Evidence map›Paper›PMID 32786065›Full record

ArticleAnnals of clinical and translational neurology2020

Augmentation in restless legs syndrome: an eye tracking study on emotion processing.

Philipp Ellmerer, Beatrice Heim, Ambra Stefani, Marina Peball, Mario Werkmann, Evi Holzknecht, Melanie Bergmann, Elisabeth Brandauer, Martin Sojer, Laura Zamarian and 5 more

Open access · goldAbstract read
In one paragraph

Article in Annals of clinical and translational neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Philipp EllmererDepartment of Neurology, Medical University of Innsbruck, Innsbruck, Austria.ORCID 0000-0001-7043-2309
Beatrice HeimDepartment of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Ambra StefaniDepartment of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Marina PeballDepartment of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Mario WerkmannDepartment of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Evi HolzknechtDepartment of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Melanie BergmannDepartment of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Elisabeth BrandauerDepartment of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Martin SojerDepartment of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Laura ZamarianDepartment of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Margarete DelazerDepartment of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Klaus SeppiDepartment of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Birgit HöglDepartment of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Werner PoeweDepartment of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Atbin DjamshidianDepartment of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Innsbruck Medical University · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo assess emotional processing and alexithymia in patients with restless legs syndrome (RLS) with augmentation versus those who never had augmentation.

methodsWe recruited 26 patients who had a history of augmentation (AUG), either current or past, 27 RLS patients treated with dopamine agonists who never had augmentation (RLS controls), and 21 healthy controls (HC). All participants were screened for impulse control disorders (ICDs). Alexithymia was assessed by means of the Toronto Alexithymia Scale - 20 (TAS-20). Facial emotion recognition was tested through an eye-tracking task. Furthermore, all participants performed neuropsychological tests assessing global cognitive status, impulsivity, anxiety, and depression.

resultsICD symptoms occurred more frequently in AUG patients than in RLS controls (P = 0.047). Patients with AUG scored higher on the TAS-20 (P = 0.007) and the attentional subdomain of an impulsivity scale (BIS-11; P = 0.015) compared to HC. Patients with AUG also performed worse on the facial emotion recognition task relative to RLS controls (P = 0.009) and HC (P = 0.003). We found a group difference for the time to first fixation and the fixation count in the mouth region (P = 0.019 and P = 0.021, respectively). There were no other differences in the eye tracking examination.

interpretationThis study showed evidence of poorer emotional processing in patients who had augmentation compared to RLS patients without augmentation and healthy controls. The altered exploration pattern of faces and the higher alexithymia scores suggest abnormalities in emotion processing in patients with augmentation.

Indexed as

Affective SymptomsAgedDisruptive, Impulse Control, and Conduct DisordersDopamine AgonistsEye-Tracking TechnologyFacial RecognitionFemaleHumansMaleMiddle AgedRestless Legs SyndromeDopamine Agonists

Identifiers

PMID32786065
PMCPMC7480921
OpenAlexW3048871736

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.